Cargando…
Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience
The coexistence of a myeloid and a lymphoid neoplasm in the same patient is a rare finding. We retrospectively searched the records of the Hematology Division of the Second Department of Internal Medicine and Research Institute at Attikon University General Hospital of Athens from 2003 to 2018. Nine...
Autores principales: | Bouchla, Anthi, Thomopoulos, Thomas, Papageorgiou, Sotirios, Tsirigotis, Panagiotis, Bazani, Efthymia, Gkirkas, Konstantinos, Vasilatou, Diamantina, Glezou, Eirini, Stavroulaki, Georgia, Gkontopoulos, Konstantinos, Dimitriadis, George, Pappa, Vasiliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875400/ https://www.ncbi.nlm.nih.gov/pubmed/31781224 http://dx.doi.org/10.1155/2019/1486476 |
Ejemplares similares
-
Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes
por: Pavlidis, George, et al.
Publicado: (2021) -
Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report
por: Bouchla, Anthi, et al.
Publicado: (2018) -
MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis
por: Papageorgiou, Sotirios G., et al.
Publicado: (2017) -
CNS Involvement in AML Patient Treated with 5-Azacytidine
por: Vasilatou, Diamantina, et al.
Publicado: (2014) -
Synergistic inhibitory effects of low-dose decitabine in combination with bortezomib in the AML cell line Kasumi-1
por: Mpakou, Vassiliki, et al.
Publicado: (2021)